Cécile Bauche
Company: Alaya.bio
Job title: Chief Scientific Officer
Seminars:
Panel Discussion: Addressing Safety of Delivery via Viral or Non-Viral Modes in Response to Concerns in the Ex Vivo Space 12:00 pm
Navigating the safety of delivery mechanisms to collaborate in ensuring vectors are as safe as possible Clarifying the latest FDA guidelines in the ex vivo CAR-T space to apply insights to the in vivo space Evaluating how this may impact in vivo pipelines using viral vectors to plan for the futureRead more
day: Conference Day Two
Examining the Use of Lentivirus Vectors as a Delivery Mechanism to Engineer Cells In Vivo 11:00 am
Showcasing platforms using viral vectors such as lentiviruses to reflect on how this technology can be used to deliver in vivo cell and gene therapies Reaffirming the safety of viral vectors to deliver cell engineering and gene editing treatmentsRead more
day: Conference Day Two